TWD
BIO icon

True Wealth Design’s Bio-Rad Laboratories Class A BIO Stock Holding History

True Wealth Design’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13K Buy
22
+2
+10% +$576 ﹤0.01% 1130
2025
Q4 		$6.06K Buy
20
+1
+5% +$312 ﹤0.01% 1015
2025
Q3 		$5.33K Buy
+19
New +$5.17K ﹤0.01% 1058
2025
Q2 		– Sell
-1
Closed -$244 – 2598
2025
Q1 		$244 Sell
1
-13
-93% -$3.91K ﹤0.01% 1871
2024
Q4 		$4.6K Buy
+14
New +$4.75K ﹤0.01% 549
2024
Q1 		– Sell
-1
Closed -$323 – 791
2023
Q4 		$323 Hold
1
– – ﹤0.01% 593
2023
Q3 		$359 Hold
1
– – ﹤0.01% 510
2023
Q2 		$380 Hold
1
– – ﹤0.01% 516
2023
Q1 		$480 Buy
+1
New +$468 ﹤0.01% 534

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return